We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-11.49%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
-$268M
Cap. Flow
-$29.5M
Cap. Flow %
-1.83%
Top 10 Hldgs %
16.63%
Holding
821
New
52
Increased
365
Reduced
330
Closed
65

Top Buys

Rank Stock Value
1
NZF icon
Nuveen Municipal Credit Income Fund
NZF
+$11.8M
2
PFFV icon
Global X Variable Rate Preferred ETF
PFFV
+$10.9M
3
MUI
BlackRock Municipal Income Fund, Inc.
MUI
+$7.58M
4
MUC icon
BlackRock MuniHoldings California Quality Fund
MUC
+$4.66M
5
NAD icon
Nuveen Quality Municipal Income Fund
NAD
+$2.6M

Top Sells

Rank Stock Value
1
NEV
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
+$17.1M
2
PFFD icon
Global X US Preferred ETF
PFFD
+$11.1M
3
MFL
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
+$6.83M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$5.13M
5
BFK
BlackRock Municipal Income Trust
BFK
+$4.3M

Sector Composition

Rank Sector Weight
1 Healthcare 13.88%
2 Financials 10.38%
3 Technology 9.18%
4 Industrials 5.61%
5 Consumer Discretionary 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
251
DELISTED
Immunogen Inc
IMGN
$1.39M 0.09%
309,334
+113,188
+58% +$492K
NEM icon
252
Newmont
NEM
$124B
$1.39M 0.09%
23,284
+3,929
+20% +$278K
FE icon
253
FirstEnergy
FE
$27.1B
$1.39M 0.09%
36,167
+11,906
+49% +$508K
VCV icon
254
Invesco California Value Municipal Income Trust
VCV
$525M
$1.38M 0.09%
130,659
-39,903
-23% -$417K
IDCC icon
255
InterDigital
IDCC
$8.99B
$1.37M 0.09%
22,557
+5,070
+29% +$311K
HUM icon
256
Humana
HUM
$46.3B
$1.36M 0.08%
2,906
+243
+9% +$108K
DCPH
257
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.36M 0.08%
103,235
+1,592
+2% +$17.6K
DTE icon
258
DTE Energy
DTE
$28.5B
$1.32M 0.08%
10,446
+984
+10% +$128K
AMD icon
259
Advanced Micro Devices
AMD
$767B
$1.32M 0.08%
17,229
-11,707
-40% -$1.1M
DLTR icon
260
Dollar Tree
DLTR
$24.9B
$1.3M 0.08%
8,314
+384
+5% +$60.8K
KPTI icon
261
Karyopharm Therapeutics
KPTI
$44.4M
$1.29M 0.08%
19,111
-6,611
-26% -$606K
IQV icon
262
IQVIA
IQV
$39.8B
$1.26M 0.08%
5,827
-125
-2% -$27.1K
GILD icon
263
Gilead Sciences
GILD
$165B
$1.25M 0.08%
20,302
+7,518
+59% +$465K
EMR icon
264
Emerson Electric
EMR
$88.5B
$1.25M 0.08%
15,759
+1,048
+7% +$92.4K
RIO icon
265
Rio Tinto
RIO
$166B
$1.25M 0.08%
20,447
+1,361
+7% +$97.5K
SYK icon
266
Stryker
SYK
$133B
$1.25M 0.08%
6,264
-3,627
-37% -$852K
G icon
267
Genpact
G
$5.74B
$1.24M 0.08%
29,377
-4,606
-14% -$195K
ACN icon
268
Accenture
ACN
$109B
$1.24M 0.08%
4,475
+108
+2% +$32.5K
MCK icon
269
McKesson
MCK
$103B
$1.23M 0.08%
+3,777
New +$1.21M
RVNC
270
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.23M 0.08%
89,020
-4,136
-4% -$63.7K
SLRC icon
271
SLR Investment Corp
SLRC
$708M
$1.23M 0.08%
83,753
-5,684
-6% -$91.3K
EMN icon
272
Eastman Chemical
EMN
$8.39B
$1.22M 0.08%
13,640
+1,140
+9% +$118K
ARCC icon
273
Ares Capital
ARCC
$14.3B
$1.22M 0.08%
68,128
+13,294
+24% +$262K
RGR icon
274
Sturm, Ruger & Co
RGR
$594M
$1.22M 0.08%
19,152
+2,524
+15% +$170K
TEI
275
Templeton Emerging Markets Income Fund
TEI
$322M
$1.21M 0.07%
223,602
+5,145
+2% +$30.8K
9 10
11
12 13

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return

Hennion & Walsh Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Hennion & Walsh Asset Management held 821 positions worth $1.61B, down 14% from $1.88B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q2 2022 filing shows 52 new, 365 increased, 330 reduced and 65 closed positions. Its largest new stake was Global X Variable Rate Preferred ETF: 442,936 shares worth $10.7M. The largest sale was NUVEEN ENHANCED MUNICIPAL VALUE FUND, an estimated $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q2 2022 buy was Global X Variable Rate Preferred ETF: 442,936 shares worth $10.7M.
  • Hennion & Walsh Asset Management added most to Nuveen Municipal Credit Income Fund in Q2 2022, an estimated $11.8M increase.
  • Hennion & Walsh Asset Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $5.13M.
  • Hennion & Walsh Asset Management fully exited NUVEEN ENHANCED MUNICIPAL VALUE FUND in Q2 2022, selling an estimated $17.1M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.61B portfolio in Q2 2022.
  • Hennion & Walsh Asset Management opened 52 new positions and closed 65 in Q2 2022.
  • Hennion & Walsh Asset Management's portfolio value fell 14% quarter-over-quarter to $1.61B.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2022, filed 19 Jul 2022.